Moline, Illinois Clinical Trials

A listing of Moline, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

oxaliplatin
metastatic colorectal adenocarcinoma
measurable disease
lithium
neutrophil count
Genesis Medical Center - East Campus
 (3.0 away) Contact site
  • 65 views
  • 22 Jul, 2021
  • +978 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

non-melanoma skin cancer
invasive carcinoma
beta human chorionic gonadotropin
lobular carcinoma
tumor cells
Trinity Medical Center
 (1.4 away) Contact site
  • 335 views
  • 21 Jul, 2021
  • +903 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

vomiting
antibiotics
bilateral oophorectomy
dexamethasone
emetics
University of Iowa Healthcare Cancer Services Quad Cities
 (3.2 away) Contact site
  • 109 views
  • 21 Jul, 2021
  • +595 other locations
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

mirikizumab
endoscopy
Gen1 - Digestive Disease Specialist
 (1.4 away) Contact site
  • 386 views
  • 21 Jul, 2021
  • +906 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

immunodeficiency
pembrolizumab
brain metastases
lung cancer
squamous non-small cell lung carcinoma
University of Iowa Healthcare Cancer Services Quad Cities
 (5.2 away) Contact site
  • 206 views
  • 15 Jul, 2021
  • +830 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

oxaliplatin
antibiotics
leucovorin
corticosteroids
monoclonal antibody therapy
Genesis Medical Center - East Campus
 (3.2 away) Contact site
  • 1047 views
  • 21 Jul, 2021
  • +588 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and blocking …

Genesis Medical Center - East Campus
 (3.2 away) Contact site
  • 836 views
  • 21 Jul, 2021
  • +755 other locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
Gen1 - Digestive Disease Specialist
 (1.4 away) Contact site
  • 1722 views
  • 21 Jul, 2021
  • +880 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

crizotinib
pembrolizumab
nivolumab
adjuvant chemotherapy
gemcitabine
Genesis Medical Center - East Campus
 (3.2 away) Contact site
  • 1103 views
  • 16 Jul, 2021
  • +1136 other locations
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such …

pertuzumab
progesterone
core needle biopsy
chemotherapy drug
neutrophil count
Genesis Medical Center - East Campus
 (3.0 away) Contact site
  • 43 views
  • 19 Jul, 2021
  • +574 other locations